Goldman Sachs Group Inc Cellebrite Di Ltd. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 112,946 shares of CLBT stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,946
Previous 112,946
-0.0%
Holding current value
$1.92 Million
Previous $2.19 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CLBT
# of Institutions
209Shares Held
90.7MCall Options Held
177KPut Options Held
84.2K-
True Wind Capital Management, L.P.13.9MShares$235 Million92.82% of portfolio
-
Morgan Stanley New York, NY3.96MShares$67.3 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA3.92MShares$66.5 Million0.22% of portfolio
-
Voss Capital, LLC Houston, TX3.84MShares$65.2 Million6.97% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.34MShares$56.7 Million0.67% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.22B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...